nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE11A—heart—hypothyroidism	0.0291	0.0623	CbGeAlD
Vardenafil—PDE11A—adrenal gland—hypothyroidism	0.0217	0.0465	CbGeAlD
Vardenafil—PDE11A—thyroid gland—hypothyroidism	0.0209	0.0449	CbGeAlD
Vardenafil—PDE6G—adrenal gland—hypothyroidism	0.0209	0.0448	CbGeAlD
Vardenafil—PDE6G—blood—hypothyroidism	0.0209	0.0448	CbGeAlD
Vardenafil—PDE10A—heart—hypothyroidism	0.0189	0.0405	CbGeAlD
Vardenafil—PDE1B—heart—hypothyroidism	0.0187	0.0402	CbGeAlD
Vardenafil—PDE11A—testis—hypothyroidism	0.0179	0.0385	CbGeAlD
Vardenafil—Angina pectoris—Liothyronine—hypothyroidism	0.0174	0.0334	CcSEcCtD
Vardenafil—PDE6G—testis—hypothyroidism	0.0173	0.037	CbGeAlD
Vardenafil—PDE11A—liver—hypothyroidism	0.017	0.0364	CbGeAlD
Vardenafil—PDE6G—liver—hypothyroidism	0.0163	0.035	CbGeAlD
Vardenafil—PDE1B—gonad—hypothyroidism	0.016	0.0344	CbGeAlD
Vardenafil—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0157	0.0301	CcSEcCtD
Vardenafil—Myocardial infarction—Liothyronine—hypothyroidism	0.0156	0.0299	CcSEcCtD
Vardenafil—PDE10A—adrenal gland—hypothyroidism	0.0141	0.0303	CbGeAlD
Vardenafil—PDE1B—adrenal gland—hypothyroidism	0.014	0.03	CbGeAlD
Vardenafil—PDE1B—blood—hypothyroidism	0.014	0.03	CbGeAlD
Vardenafil—PDE10A—thyroid gland—hypothyroidism	0.0136	0.0292	CbGeAlD
Vardenafil—PDE1B—thyroid gland—hypothyroidism	0.0135	0.0289	CbGeAlD
Vardenafil—CYP3A4—urine—hypothyroidism	0.0135	0.0289	CbGeAlD
Vardenafil—PDE10A—female gonad—hypothyroidism	0.0132	0.0282	CbGeAlD
Vardenafil—Feeling hot—Liotrix—hypothyroidism	0.0131	0.0251	CcSEcCtD
Vardenafil—PDE10A—testis—hypothyroidism	0.0117	0.025	CbGeAlD
Vardenafil—PDE1B—testis—hypothyroidism	0.0116	0.0248	CbGeAlD
Vardenafil—PDE5A—heart—hypothyroidism	0.0111	0.0237	CbGeAlD
Vardenafil—Creatinine increased—Liotrix—hypothyroidism	0.0108	0.0207	CcSEcCtD
Vardenafil—PDE10A—cerebellum—hypothyroidism	0.0108	0.0231	CbGeAlD
Vardenafil—PDE1B—cerebellum—hypothyroidism	0.0107	0.0229	CbGeAlD
Vardenafil—PDE5A—cardiovascular system—hypothyroidism	0.0104	0.0224	CbGeAlD
Vardenafil—Tachycardia—Liothyronine—hypothyroidism	0.00992	0.019	CcSEcCtD
Vardenafil—Hypotension—Liothyronine—hypothyroidism	0.0095	0.0182	CcSEcCtD
Vardenafil—PDE5A—gonad—hypothyroidism	0.00947	0.0203	CbGeAlD
Vardenafil—Dysphagia—Levothyroxine—hypothyroidism	0.00878	0.0168	CcSEcCtD
Vardenafil—Dysphagia—Dextrothyroxine—hypothyroidism	0.00878	0.0168	CcSEcCtD
Vardenafil—Angina pectoris—Levothyroxine—hypothyroidism	0.00855	0.0164	CcSEcCtD
Vardenafil—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00855	0.0164	CcSEcCtD
Vardenafil—PDE5A—adrenal gland—hypothyroidism	0.00825	0.0177	CbGeAlD
Vardenafil—PDE5A—blood—hypothyroidism	0.00825	0.0177	CbGeAlD
Vardenafil—PDE5A—thyroid gland—hypothyroidism	0.00796	0.0171	CbGeAlD
Vardenafil—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00771	0.0148	CcSEcCtD
Vardenafil—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00771	0.0148	CcSEcCtD
Vardenafil—PDE5A—female gonad—hypothyroidism	0.00769	0.0165	CbGeAlD
Vardenafil—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00767	0.0147	CcSEcCtD
Vardenafil—Myocardial infarction—Levothyroxine—hypothyroidism	0.00767	0.0147	CcSEcCtD
Vardenafil—Sweating—Dextrothyroxine—hypothyroidism	0.0075	0.0144	CcSEcCtD
Vardenafil—Sweating—Levothyroxine—hypothyroidism	0.0075	0.0144	CcSEcCtD
Vardenafil—Blood creatinine increased—Liotrix—hypothyroidism	0.007	0.0134	CcSEcCtD
Vardenafil—PDE5A—testis—hypothyroidism	0.00682	0.0146	CbGeAlD
Vardenafil—Flushing—Dextrothyroxine—hypothyroidism	0.00652	0.0125	CcSEcCtD
Vardenafil—Flushing—Levothyroxine—hypothyroidism	0.00652	0.0125	CcSEcCtD
Vardenafil—Dysphagia—Liotrix—hypothyroidism	0.00646	0.0124	CcSEcCtD
Vardenafil—PDE5A—cerebellum—hypothyroidism	0.0063	0.0135	CbGeAlD
Vardenafil—Angina pectoris—Liotrix—hypothyroidism	0.00629	0.0121	CcSEcCtD
Vardenafil—Acute coronary syndrome—Liotrix—hypothyroidism	0.00567	0.0109	CcSEcCtD
Vardenafil—Myocardial infarction—Liotrix—hypothyroidism	0.00564	0.0108	CcSEcCtD
Vardenafil—Angioedema—Levothyroxine—hypothyroidism	0.00559	0.0107	CcSEcCtD
Vardenafil—Angioedema—Dextrothyroxine—hypothyroidism	0.00559	0.0107	CcSEcCtD
Vardenafil—Sweating—Liotrix—hypothyroidism	0.00552	0.0106	CcSEcCtD
Vardenafil—Palpitations—Levothyroxine—hypothyroidism	0.0054	0.0104	CcSEcCtD
Vardenafil—Palpitations—Dextrothyroxine—hypothyroidism	0.0054	0.0104	CcSEcCtD
Vardenafil—Convulsion—Dextrothyroxine—hypothyroidism	0.0053	0.0102	CcSEcCtD
Vardenafil—Convulsion—Levothyroxine—hypothyroidism	0.0053	0.0102	CcSEcCtD
Vardenafil—Arthralgia—Levothyroxine—hypothyroidism	0.00521	0.00998	CcSEcCtD
Vardenafil—Arthralgia—Dextrothyroxine—hypothyroidism	0.00521	0.00998	CcSEcCtD
Vardenafil—Anxiety—Levothyroxine—hypothyroidism	0.00519	0.00994	CcSEcCtD
Vardenafil—Anxiety—Dextrothyroxine—hypothyroidism	0.00519	0.00994	CcSEcCtD
Vardenafil—Hypoaesthesia—Liotrix—hypothyroidism	0.00514	0.00985	CcSEcCtD
Vardenafil—Shock—Dextrothyroxine—hypothyroidism	0.00491	0.00941	CcSEcCtD
Vardenafil—Shock—Levothyroxine—hypothyroidism	0.00491	0.00941	CcSEcCtD
Vardenafil—Tachycardia—Dextrothyroxine—hypothyroidism	0.00487	0.00934	CcSEcCtD
Vardenafil—Tachycardia—Levothyroxine—hypothyroidism	0.00487	0.00934	CcSEcCtD
Vardenafil—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00482	0.00925	CcSEcCtD
Vardenafil—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00482	0.00925	CcSEcCtD
Vardenafil—Flushing—Liotrix—hypothyroidism	0.0048	0.00919	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00455	0.00871	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00455	0.00871	CcSEcCtD
Vardenafil—Insomnia—Dextrothyroxine—hypothyroidism	0.00451	0.00865	CcSEcCtD
Vardenafil—Insomnia—Levothyroxine—hypothyroidism	0.00451	0.00865	CcSEcCtD
Vardenafil—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00445	0.00853	CcSEcCtD
Vardenafil—Dyspnoea—Levothyroxine—hypothyroidism	0.00445	0.00853	CcSEcCtD
Vardenafil—Vision blurred—Liotrix—hypothyroidism	0.00424	0.00813	CcSEcCtD
Vardenafil—Feeling abnormal—Levothyroxine—hypothyroidism	0.00411	0.00788	CcSEcCtD
Vardenafil—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00411	0.00788	CcSEcCtD
Vardenafil—Angioedema—Liotrix—hypothyroidism	0.00411	0.00788	CcSEcCtD
Vardenafil—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00408	0.00782	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00408	0.00782	CcSEcCtD
Vardenafil—Syncope—Liotrix—hypothyroidism	0.00403	0.00773	CcSEcCtD
Vardenafil—Palpitations—Liotrix—hypothyroidism	0.00398	0.00762	CcSEcCtD
Vardenafil—Loss of consciousness—Liotrix—hypothyroidism	0.00395	0.00758	CcSEcCtD
Vardenafil—Abdominal pain—Levothyroxine—hypothyroidism	0.00395	0.00756	CcSEcCtD
Vardenafil—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00395	0.00756	CcSEcCtD
Vardenafil—Convulsion—Liotrix—hypothyroidism	0.0039	0.00747	CcSEcCtD
Vardenafil—Chest pain—Liotrix—hypothyroidism	0.00383	0.00734	CcSEcCtD
Vardenafil—Arthralgia—Liotrix—hypothyroidism	0.00383	0.00734	CcSEcCtD
Vardenafil—Anxiety—Liotrix—hypothyroidism	0.00382	0.00731	CcSEcCtD
Vardenafil—Anaphylactic shock—Liotrix—hypothyroidism	0.00367	0.00704	CcSEcCtD
Vardenafil—Infection—Liotrix—hypothyroidism	0.00365	0.00699	CcSEcCtD
Vardenafil—Shock—Liotrix—hypothyroidism	0.00361	0.00692	CcSEcCtD
Vardenafil—Tachycardia—Liotrix—hypothyroidism	0.00358	0.00687	CcSEcCtD
Vardenafil—Asthenia—Dextrothyroxine—hypothyroidism	0.00358	0.00686	CcSEcCtD
Vardenafil—Asthenia—Levothyroxine—hypothyroidism	0.00358	0.00686	CcSEcCtD
Vardenafil—Hyperhidrosis—Liotrix—hypothyroidism	0.00355	0.0068	CcSEcCtD
Vardenafil—Pruritus—Dextrothyroxine—hypothyroidism	0.00353	0.00677	CcSEcCtD
Vardenafil—Pruritus—Levothyroxine—hypothyroidism	0.00353	0.00677	CcSEcCtD
Vardenafil—Hypotension—Liotrix—hypothyroidism	0.00343	0.00657	CcSEcCtD
Vardenafil—CYP3A5—blood—hypothyroidism	0.00343	0.00735	CbGeAlD
Vardenafil—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00341	0.00654	CcSEcCtD
Vardenafil—Diarrhoea—Levothyroxine—hypothyroidism	0.00341	0.00654	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00334	0.00641	CcSEcCtD
Vardenafil—Insomnia—Liotrix—hypothyroidism	0.00332	0.00636	CcSEcCtD
Vardenafil—Paraesthesia—Liotrix—hypothyroidism	0.0033	0.00632	CcSEcCtD
Vardenafil—Dyspnoea—Liotrix—hypothyroidism	0.00327	0.00627	CcSEcCtD
Vardenafil—CYP3A5—female gonad—hypothyroidism	0.0032	0.00686	CbGeAlD
Vardenafil—Vomiting—Dextrothyroxine—hypothyroidism	0.00317	0.00608	CcSEcCtD
Vardenafil—Vomiting—Levothyroxine—hypothyroidism	0.00317	0.00608	CcSEcCtD
Vardenafil—Rash—Levothyroxine—hypothyroidism	0.00315	0.00603	CcSEcCtD
Vardenafil—Rash—Dextrothyroxine—hypothyroidism	0.00315	0.00603	CcSEcCtD
Vardenafil—Dermatitis—Levothyroxine—hypothyroidism	0.00314	0.00603	CcSEcCtD
Vardenafil—Dermatitis—Dextrothyroxine—hypothyroidism	0.00314	0.00603	CcSEcCtD
Vardenafil—Headache—Dextrothyroxine—hypothyroidism	0.00313	0.00599	CcSEcCtD
Vardenafil—Headache—Levothyroxine—hypothyroidism	0.00313	0.00599	CcSEcCtD
Vardenafil—Feeling abnormal—Liotrix—hypothyroidism	0.00303	0.0058	CcSEcCtD
Vardenafil—Gastrointestinal pain—Liotrix—hypothyroidism	0.003	0.00575	CcSEcCtD
Vardenafil—Nausea—Dextrothyroxine—hypothyroidism	0.00296	0.00568	CcSEcCtD
Vardenafil—Nausea—Levothyroxine—hypothyroidism	0.00296	0.00568	CcSEcCtD
Vardenafil—Abdominal pain—Liotrix—hypothyroidism	0.0029	0.00556	CcSEcCtD
Vardenafil—Hypersensitivity—Liotrix—hypothyroidism	0.0027	0.00518	CcSEcCtD
Vardenafil—CYP3A5—liver—hypothyroidism	0.00268	0.00575	CbGeAlD
Vardenafil—Asthenia—Liotrix—hypothyroidism	0.00263	0.00505	CcSEcCtD
Vardenafil—Pruritus—Liotrix—hypothyroidism	0.0026	0.00498	CcSEcCtD
Vardenafil—CYP3A4—blood—hypothyroidism	0.00257	0.00552	CbGeAlD
Vardenafil—Diarrhoea—Liotrix—hypothyroidism	0.00251	0.00481	CcSEcCtD
Vardenafil—Dizziness—Liotrix—hypothyroidism	0.00243	0.00465	CcSEcCtD
Vardenafil—Vomiting—Liotrix—hypothyroidism	0.00233	0.00447	CcSEcCtD
Vardenafil—Rash—Liotrix—hypothyroidism	0.00231	0.00444	CcSEcCtD
Vardenafil—Dermatitis—Liotrix—hypothyroidism	0.00231	0.00443	CcSEcCtD
Vardenafil—Headache—Liotrix—hypothyroidism	0.0023	0.00441	CcSEcCtD
Vardenafil—Nausea—Liotrix—hypothyroidism	0.00218	0.00418	CcSEcCtD
Vardenafil—CYP3A4—liver—hypothyroidism	0.00201	0.00432	CbGeAlD
Vardenafil—PDE6G—beta-catenin independent WNT signaling—CLTC—hypothyroidism	0.000649	0.0536	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—TSHB—hypothyroidism	0.000613	0.0506	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—TSHR—hypothyroidism	0.000613	0.0506	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—TSHB—hypothyroidism	0.000546	0.0451	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—TSHR—hypothyroidism	0.000546	0.0451	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—AVP—hypothyroidism	0.000361	0.0298	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—CLTC—hypothyroidism	0.000343	0.0284	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—AVP—hypothyroidism	0.000322	0.0266	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—TSHB—hypothyroidism	0.000277	0.0229	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—TSHR—hypothyroidism	0.000277	0.0229	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—POMC—hypothyroidism	0.00024	0.0198	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—POMC—hypothyroidism	0.000214	0.0177	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—SH2B3—hypothyroidism	0.000177	0.0146	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—AVP—hypothyroidism	0.000163	0.0135	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—SH2B3—hypothyroidism	0.000158	0.0131	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—SH2B3—hypothyroidism	0.000158	0.0131	CbGpPWpGaD
Vardenafil—PDE1B—Opioid Signalling—POMC—hypothyroidism	0.000152	0.0126	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—TRH—hypothyroidism	0.000141	0.0116	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—VAV3—hypothyroidism	0.000135	0.0112	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TRH—hypothyroidism	0.000128	0.0106	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—VAV3—hypothyroidism	0.000127	0.0105	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—TSHB—hypothyroidism	0.000126	0.0104	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—TSHR—hypothyroidism	0.000126	0.0104	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—TRH—hypothyroidism	0.000126	0.0104	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—VAV3—hypothyroidism	0.000122	0.0101	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TRH—hypothyroidism	0.000114	0.00943	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TSHR—hypothyroidism	0.000114	0.00943	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TSHB—hypothyroidism	0.000114	0.00943	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—TSHB—hypothyroidism	0.000112	0.00925	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—TSHR—hypothyroidism	0.000112	0.00925	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—VAV3—hypothyroidism	0.000109	0.00896	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—VAV3—hypothyroidism	0.000109	0.00896	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—POMC—hypothyroidism	0.000108	0.00895	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TSHB—hypothyroidism	0.000102	0.0084	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TSHR—hypothyroidism	0.000102	0.0084	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CLTC—hypothyroidism	8.76e-05	0.00723	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—VAV3—hypothyroidism	8.68e-05	0.00717	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SH2B3—hypothyroidism	8.01e-05	0.00661	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CLTC—hypothyroidism	8.01e-05	0.00661	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CLTC—hypothyroidism	7.81e-05	0.00644	CbGpPWpGaD
Vardenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.72e-05	0.00637	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—VAV3—hypothyroidism	7.69e-05	0.00635	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TRH—hypothyroidism	7.57e-05	0.00625	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—IGF1—hypothyroidism	7.5e-05	0.00619	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AVP—hypothyroidism	7.41e-05	0.00612	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—VAV3—hypothyroidism	6.99e-05	0.00577	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TRH—hypothyroidism	6.92e-05	0.00572	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—VAV3—hypothyroidism	6.86e-05	0.00566	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TSHB—hypothyroidism	6.75e-05	0.00557	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TRH—hypothyroidism	6.75e-05	0.00557	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TSHR—hypothyroidism	6.75e-05	0.00557	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AVP—hypothyroidism	6.73e-05	0.00556	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—IGF1—hypothyroidism	6.68e-05	0.00552	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—IGF1—hypothyroidism	6.68e-05	0.00552	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AVP—hypothyroidism	6.61e-05	0.00545	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TRH—hypothyroidism	6.37e-05	0.00526	CbGpPWpGaD
Vardenafil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.26e-05	0.00517	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—VAV3—hypothyroidism	6.23e-05	0.00514	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TSHB—hypothyroidism	6.17e-05	0.00509	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TSHR—hypothyroidism	6.17e-05	0.00509	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CLTC—hypothyroidism	6.12e-05	0.00505	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SH2B3—hypothyroidism	6.01e-05	0.00496	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TSHB—hypothyroidism	6.01e-05	0.00496	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TSHR—hypothyroidism	6.01e-05	0.00496	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AVP—hypothyroidism	6e-05	0.00495	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PRL—hypothyroidism	5.83e-05	0.00481	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TRH—hypothyroidism	5.79e-05	0.00478	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TSHB—hypothyroidism	5.68e-05	0.00469	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TSHR—hypothyroidism	5.68e-05	0.00469	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SH2B3—hypothyroidism	5.5e-05	0.00454	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VAV3—hypothyroidism	5.5e-05	0.00454	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SH2B3—hypothyroidism	5.36e-05	0.00442	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TSHR—hypothyroidism	5.16e-05	0.00426	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TSHB—hypothyroidism	5.16e-05	0.00426	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—VAV3—hypothyroidism	4.95e-05	0.00409	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—POMC—hypothyroidism	4.93e-05	0.00407	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—POMC—hypothyroidism	4.47e-05	0.00369	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PRL—hypothyroidism	4.46e-05	0.00368	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—POMC—hypothyroidism	4.39e-05	0.00362	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VAV3—hypothyroidism	4.13e-05	0.00341	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PRL—hypothyroidism	4.08e-05	0.00337	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—POMC—hypothyroidism	3.99e-05	0.00329	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AVP—hypothyroidism	3.98e-05	0.00328	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PRL—hypothyroidism	3.98e-05	0.00328	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CLTC—hypothyroidism	3.96e-05	0.00327	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—IYD—hypothyroidism	3.92e-05	0.00324	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VAV3—hypothyroidism	3.77e-05	0.00312	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VAV3—hypothyroidism	3.68e-05	0.00304	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AVP—hypothyroidism	3.64e-05	0.003	CbGpPWpGaD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.59e-05	0.00296	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AVP—hypothyroidism	3.54e-05	0.00293	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—VAV3—hypothyroidism	3.48e-05	0.00287	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TRH—hypothyroidism	3.42e-05	0.00282	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IGF1—hypothyroidism	3.39e-05	0.0028	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AVP—hypothyroidism	3.35e-05	0.00276	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ATP5O—hypothyroidism	3.33e-05	0.00275	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—POMC—hypothyroidism	3.32e-05	0.00274	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—VAV3—hypothyroidism	3.16e-05	0.00261	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TPO—hypothyroidism	3.13e-05	0.00259	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PRL—hypothyroidism	3.12e-05	0.00257	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSHB—hypothyroidism	3.05e-05	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSHR—hypothyroidism	3.05e-05	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AVP—hypothyroidism	3.04e-05	0.00251	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.91e-05	0.0024	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—VAV3—hypothyroidism	2.88e-05	0.00238	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PRL—hypothyroidism	2.88e-05	0.00238	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SH2B3—hypothyroidism	2.72e-05	0.00224	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—POMC—hypothyroidism	2.64e-05	0.00218	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF1—hypothyroidism	2.54e-05	0.0021	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—hypothyroidism	2.42e-05	0.002	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—hypothyroidism	2.36e-05	0.00194	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF1—hypothyroidism	2.32e-05	0.00192	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF1—hypothyroidism	2.27e-05	0.00187	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—hypothyroidism	2.23e-05	0.00184	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—hypothyroidism	2.02e-05	0.00167	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRL—hypothyroidism	2.02e-05	0.00166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VAV3—hypothyroidism	1.86e-05	0.00154	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IYD—hypothyroidism	1.82e-05	0.00151	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AVP—hypothyroidism	1.8e-05	0.00148	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.55e-05	0.00128	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.55e-05	0.00128	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TPO—hypothyroidism	1.46e-05	0.0012	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TSHB—hypothyroidism	1.45e-05	0.0012	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.29e-05	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—hypothyroidism	1.19e-05	0.000985	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—hypothyroidism	1.15e-05	0.000948	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.09e-05	0.000897	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TSHB—hypothyroidism	6.75e-06	0.000557	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	6.01e-06	0.000496	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—hypothyroidism	5.68e-06	0.000469	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC5A5—hypothyroidism	5.05e-06	0.000417	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—hypothyroidism	2.64e-06	0.000218	CbGpPWpGaD
